How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient's perception: Study on 600 patients on biologic therapy

• Main Authors: N. Bernardini (Author), N. Skroza (Author), A. Spagnoli (Author), A. Marchesiello (Author), V. Balduzzi (Author), E. Tolino (Author), A. Mambrin (Author), S. Michelini (Author), P. Maddalena (Author), S. Volpe (Author), I. Proietti (Author), A. Vestri (Author), C. Potenza (Author)
• Format: Book
• Published: Elsevier, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The outbreak of coronavirus disease-2019 (COVID-19) is a public health crisis of global proportion. In psoriatic patients treated with biologic agents, evidence is not yet available on susceptibility to infection with the novel SARS-CoV-2 coronavirus, and data about the perception of COV...